BrillianceTube: Market Launch of Decorated Packaging
Sanner GmbH, a manufacturer of high-quality plastic packaging for pharmaceutical, medical and healthcare products, is expanding its portfolio. The new BrillianceTube for effervescent tablets with in-mold labeling (IML) and the proven desiccant closures offers customers a complete solution.
Photorealistic printing and more legible product information are some of the advantages of the newly launched BrillianceTube packaging from Sanner GmbH. Combined with proven Sanner desiccant closures, the tubes are best suited for effervescent tablets, but also work with conventional or coated tablets and other solid pharmaceutical products. Manufactured using IML technology, the packaging offers customers a wide range of design options and a premium-quality appearance. BrillianceTubes combined with proven Sanner desiccant closures protect their contents perfectly against light and moisture.
The advantage of IML technology is that packaging production and decoration are combined into a single process. Printed labels are placed in the mold and the liquid plastic is injected. The temperature of the plastic causes the label to fully bond with the tube. Additionally the geometry of the tube base ensures that the tubes can be easily packaged in standard commercial sales trays.
Expansion of Effervescent Packaging Product Range
"The development of Brilliance underscores our leadership position in the field of effervescent packaging. It is especially important for us to support our customers as a system supplier across the entire supply chain," explained Sanner CEO Holger Frank. This includes the systematic development of efficient logistical solutions. Sanner customers get everything from a single source: from printed labels and the manufacturing of decorated tubes up to delivery. "Our customers can always rely on proven Sanner quality. In addition, having a centrally-located contact reduces organizational effort,” Frank emphasized. "Our customers can efficiently purchase their decorated tubes with different fitting types of closures. Thus, Brilliance enables us to meet customer demands with more flexibility."
More Attention at the Point of Sale
Unlike conventional printed packaging, tubes manufactured using the IML technology offer high quality, photorealistic printing with a choice of textures and finishes. Up to eight colours and metallic effects are possible to make packaging stand out at the point of sale. Labels that are easy to read with smaller font sizes provide more space for important product information. The high-impact, scratch-resistant material is extremely durable. Using modern communication media such as integrated QR codes makes it easier for customers to access additional information about the manufacturer and product.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.